Featured
How many of the best US drugs have reached Australia?
Just three of the 21 drugs named finalists for the prestigious 2026 Prix Galien USA Awards in the best pharmaceutical product category are currently subsidised in Australia
Featured
Swedish pharma launches first drug
The first commercial patient has received a living donor kidney transplant following treatment with a drug that was approved by the TGA three years ago and was finally added to National Health Reform Agreement last month
Regulatory & Reimbursement
17 drugs vie for September PBS listing
A bumper start to Spring is on the cards with a long list of submissions recommended by the PBAC currently sitting in the last stage before listing occurs
Industry & Companies
Pharma a bright spot in CSL's "reset" year
In a year of declining revenue and a multi-billion dollar reported loss, the local giant had strong growth in many of its pharma products
Latest
The hidden $1.2B cost of two diseases
Two rare autoimmune diseases are costing Australians and the health system $1.2B every year, a new argenx backed report shows
Industry & Companies
Novo teams up with Rural Doctors Foundation
Oceania GM, Michael Azrak, says the company is committed to being a trusted healthcare partner and working alongside like-minded organisations
Featured
NEXT Summit in full swing in Sydney
Hundreds of pharma professionals have turned out for this year's much-anticipated NEXT Pharma Summit in Sydney for a sizzling hot conversation about the state of the local industry
Regulatory & Reimbursement
Blockbuster earnings nosedive by 80%
When this top-earning PBS drug faced generic competition a year ago, a drop in price was expected but not the calamitous fall that actually occured
Regulatory & Reimbursement
14 drugs land on TGA's review desk
An update to the regulator's list of prescription medicines under review, shows six new drugs and eight new indications were accepted in June
Regulatory & Reimbursement
Fast response after PBAC Special Meeting
A snap meeting of the PBAC to replace a treatment being withdrawn from Australia has seen a result barely two weeks later
Latest
Pharma boosts pipeline to 39 assets
A new strategic collaboration worth up to $453 million has expanded this company's pipeline to 39 biosimilars, with potential to increase up to 46
Jobs
-
Clinical Specialist New
-
Regulatory Affairs Associate New
-
Marketing Manager New
-
Clinical Specialist New
-
Territory Manager - Devices New
-
Senior Brand Manager New
-
Logistics and Customer Service Specialist New
-
Clinical Research Associate New
-
Quality Engineer New
-
Territory Manager & Clinical Specialist New
Jobs & Workplace
Big Pharma on Aussie hiring spree
In a breath of fresh air for the Australian industry - which has been hit hard by years of workforce downsizing across multiple companies - this Big Pharma is on a hiring spree
Industry & Companies
Who's the Most Productive pharma?
The inaugural Pipeline-to-Productivity Index is out - measuring R&D productivity, market access, and commercial return across the top 25 global pharmas
Regulatory & Reimbursement
Next stop Australia for 'oncology cornerstone'?
Potential best-in-class therapy and first anticancer treatment to be administered via an on-body injector could be heading Down Under
Regulatory & Reimbursement
Pharma expands offering in hotly contested space
The TGA has approved a new presentation of this company's RSV jab as it seeks to expand its reach in a competitive market by targeting a younger cohort
- Jobs & Workplace What happened to the Aussie pharma career ladder?
- Industry & Companies Sydney to host world RNA conference
- Regulatory & Reimbursement Johnson & Johnson pulls another drug
- Leadership & People AbbVie exec jumps to Medicines Australia
- Other News 'GLP-1 Brides' have a new problem to weigh
- Industry & Companies Lilly CEO calls out PBS pricing on Aussie TV
- Industry & Companies Gene therapy could put sleep problem to bed
- Other News What's on Doctors' pharma wish list?
- Other News Oncologists emotionally connect to pharma brands
- Leadership & People Med Affairs boss stars on ABC TV show
